Andrew Potler
Internal Medicine · Gt Barrington, MANPI 1427149798
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by GSK at 35.0% of the total.
Across 48 payments — averaging $13.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$228
- AstraZeneca$75
- Johnson & Johnson$74
- Merck$42
- Lilly USA, LLC$39
- Pfizer$25
- plus $169 from 10 others
Across 107 payments — averaging $736.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$33K
- Boehringer Ingelheim Pharma GmbH & Co.kg$29K
- Boehringer Ingelheim International GmbH$16K
What the payments were for
- Food & beverage$651100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 18 | $228 |
| AstraZeneca | 5 | $75 |
| Johnson & Johnson | 5 | $74 |
| Merck | 3 | $42 |
| Lilly USA, LLC | 3 | $39 |
| Pfizer | 2 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Novartis | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $20 |
| Amgen | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Gilead | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Novo Nordisk | 1 | $11 |
| AbbVie | 1 | $11 |
How this compares
$651 in reported general payments places this provider in the 80th percentile of 4,983 internal medicine providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 13 | $9,649 |
| Rosuvastatin Calcium | 15 | $660 |
| Atorvastatin Calcium | 24 | $312 |
| Losartan Potassium | 18 | $289 |
| Fluticasone Propionate | 14 | $168 |
| Trazodone Hcl | 18 | $97 |
| Amlodipine Besylate | 11 | $80 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Gt Barrington
- David SchenkeinBoston$5M
- Alan GarberCambridge$4.9M
- John FallonBoston$1.8M
- Michael MendelsohnBoston$1.6M
- Sandra RichmanBrookline$1.4M
- Gaurav SingalBoston$798K
- Asit ParikhBoston$486K
- Noopur RajeBoston$481K
- Daniel KuritzkesBoston$443K
- Xiuning leBoston$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.